Basic Information
| RNALocate ID: | RLID:11001872 |
| RNA Symbol: | hsa-miR-126-5p |
| Localization: | Extracellular vesicle |
RNA Information
| RNA Name: | hsa-miR-126-5p |
| RNA ID: | miRBase:MIMAT0000444 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 32498409 |
| Tissue/Cell Line: | Plasma |
| Method: | qRT-PCR |
|
Originally published in Cancers (Basel). Dias F, et al, 2020. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
| Description: | Focusing on the patients from Group A, we observed that the levels of EV-derived hsa-miR-25-3p (p = 0.003), hsa-miR-126-5p (p < 0.001), hsa-miR-200c-3p (p < 0.001) and hsa-miR-301a-3p (p = 0.006) decreased after surgery (Figure 2A-C,E). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11001869 | Exosome | Breast milk | 22211110 |
| RLID:11001870 | Exosome | Brain tissue | 23382797 |
| RLID:11001871 | Exosome | Plasma | 23663360 |
| RLID:11001873 | Microvesicle | Plasma | 19002258 |
| RLID:11001874 | Microvesicle | Plasma | 23077538 |
| RLID-D:11000092 | Exosome | Blood|B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue|Mast cells | |
| RLID-D:11000372 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-126-5p | Diffuse large b cell lymphoma | MNDR-E-MI-08083 |
| MNDR | hsa-miR-126-5p | Splenic marginal zone lymphoma | MNDR-E-MI-08084 |
| MNDR | hsa-miR-126-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-08085 |
| MNDR | hsa-miR-126-5p | Peripheral artery disease | MNDR-E-MI-08086 |
| MNDR | hsa-miR-126-5p | Large cell neuroendocrine cancer | MNDR-E-MI-08087 |
| MNDR | hsa-miR-126-5p | Medulloblastoma | MNDR-E-MI-08088 |
| MNDR | hsa-miR-126-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-08089 |
| MNDR | hsa-miR-126-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-08090 |
| MNDR | hsa-miR-126-5p | Lymphoma | MNDR-E-MI-08091 |
| MNDR | hsa-miR-126-5p | Lymphoma non-hodgkin | MNDR-E-MI-08092 |
| MNDR | hsa-miR-126-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-08093 |
| MNDR | hsa-miR-126-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-08094 |
| MNDR | hsa-miR-126-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-08095 |
| MNDR | hsa-miR-126-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-08096 |
| MNDR | hsa-miR-126-5p | Her2-receptor positive breast cancer | MNDR-E-MI-08097 |
| MNDR | hsa-miR-126-5p | Breast cancer luminal b | MNDR-E-MI-08098 |
| MNDR | hsa-miR-126-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-08099 |
| MNDR | hsa-miR-126-5p | Dermatomyositis | MNDR-E-MI-08100 |
| MNDR | hsa-miR-126-5p | Prostate cancer | MNDR-E-MI-08101 |
| MNDR | hsa-miR-126-5p | Gastric cancer | MNDR-E-MI-08102 |
| MNDR | hsa-miR-126-5p | Alzheimer disease | MNDR-E-MI-08103 |
| MNDR | hsa-miR-126-5p | Right ventricular hypertension | MNDR-E-MI-08104 |
| MNDR | hsa-miR-126-5p | Intracranial aneurysm | MNDR-E-MI-08105 |
| MNDR | hsa-miR-126-5p | Brucellosis | MNDR-E-MI-08106 |
| MNDR | hsa-miR-126-5p | Head and neck cancer | MNDR-E-MI-08107 |
| MNDR | hsa-miR-126-5p | Huntington disease | MNDR-E-MI-08108 |
| MNDR | hsa-miR-126-5p | Chorea | MNDR-E-MI-08109 |
| MNDR | hsa-miR-126-5p | Cardiovascular disease | MNDR-E-MI-08110 |
| MNDR | hsa-miR-126-5p | Lung cancer | MNDR-E-MI-08111 |
| MNDR | hsa-miR-126-5p | Parkinson disease | MNDR-E-MI-08112 |
| MNDR | hsa-miR-126-5p | Basal-like breast cancer | MNDR-E-MI-08113 |
| MNDR | hsa-miR-126-5p | Pituitary neoplasms | MNDR-E-MI-08114 |
| MNDR | hsa-miR-126-5p | Pancreatic cancer | MNDR-E-MI-08115 |
| MNDR | hsa-miR-126-5p | Melanoma | MNDR-E-MI-08116 |
| MNDR | hsa-miR-126-5p | Rectum adenocarcinoma | MNDR-E-MI-08117 |
| MNDR | hsa-miR-126-5p | Colon cancer | MNDR-E-MI-08118 |
| MNDR | hsa-miR-126-5p | Ischemic attack transient | MNDR-E-MI-08119 |
| MNDR | hsa-miR-126-5p | Colon adenocarcinoma | MNDR-E-MI-08120 |
| MNDR | hsa-miR-126-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-08121 |
| MNDR | hsa-miR-126-5p | Familial ovarian cancer | MNDR-E-MI-08122 |
| MNDR | hsa-miR-126-5p | Prostate adenocarcinoma | MNDR-E-MI-08123 |
| MNDR | hsa-miR-126-5p | Carcinoma ductal breast | MNDR-E-MI-08124 |
| MNDR | hsa-miR-126-5p | Acute kidney injury | MNDR-E-MI-08125 |
| MNDR | hsa-miR-126-5p | Glioblastoma | MNDR-E-MI-08126 |
| MNDR | hsa-miR-126-5p | Glioma | MNDR-E-MI-08127 |
| MNDR | hsa-miR-126-5p | Epilepsy temporal lobe | MNDR-E-MI-08128 |
| MNDR | hsa-miR-126-5p | Osteosarcoma | MNDR-E-MI-08129 |
| MNDR | hsa-miR-126-5p | Liposarcoma | MNDR-E-MI-08130 |
| MNDR | hsa-miR-126-5p | Coronary artery disease | MNDR-E-MI-08131 |
| MNDR | hsa-miR-126-5p | Inclusion body myositis | MNDR-E-MI-08132 |
| MNDR | hsa-miR-126-5p | Breast carcinoma | MNDR-E-MI-08133 |
| MNDR | hsa-miR-126-5p | Uterine cancer | MNDR-E-MI-08134 |
| MNDR | hsa-miR-126-5p | Cervical squamous cell carcinoma | MNDR-E-MI-08135 |
| MNDR | hsa-miR-126-5p | Pituitary adenoma | MNDR-E-MI-08136 |
| MNDR | hsa-miR-126-5p | Lung squamous cell carcinoma | MNDR-E-MI-08137 |
| MNDR | hsa-miR-126-5p | Carcinoma lung non-small-cell | MNDR-E-MI-08138 |
| MNDR | hsa-miR-126-5p | Lung adenocarcinoma | MNDR-E-MI-08139 |
| MNDR | hsa-miR-126-5p | Adrenocortical carcinoma | MNDR-E-MI-08140 |
| MNDR | hsa-miR-126-5p | Thyroid carcinoma | MNDR-E-MI-08141 |
| MNDR | hsa-miR-126-5p | Tuberculosis | MNDR-E-MI-08142 |
| MNDR | hsa-miR-126-5p | Ovarian carcinoma | MNDR-E-MI-08143 |
| MNDR | hsa-miR-126-5p | Pancreatic adenocarcinoma | MNDR-E-MI-08144 |
| MNDR | hsa-miR-126-5p | Cervical cancer | MNDR-E-MI-08145 |
| MNDR | hsa-miR-126-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-08146 |
| MNDR | hsa-miR-126-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-08147 |
| MNDR | hsa-miR-126-5p | Clear cell renal cell carcinoma | MNDR-E-MI-08148 |
| MNDR | hsa-miR-126-5p | Liver cirrhosis | MNDR-E-MI-08149 |
| MNDR | hsa-miR-126-5p | Prolactinoma | MNDR-E-MI-08150 |
| MNDR | hsa-miR-126-5p | Lung small cell carcinoma | MNDR-E-MI-08151 |
| MNDR | hsa-miR-126-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-08152 |
| MNDR | hsa-miR-126-5p | Fibromyalgia | MNDR-E-MI-08153 |
| MNDR | hsa-miR-126-5p | Breast invasive carcinoma | MNDR-E-MI-08154 |
| MNDR | hsa-miR-126-5p | Hepatocellular carcinoma | MNDR-E-MI-08155 |
| MNDR | hsa-miR-126-5p | Familiar ovarian carcinoma | MNDR-E-MI-08156 |
| MNDR | hsa-miR-126-5p | B-cell lymphoma | MNDR-E-MI-08157 |
| MNDR | hsa-miR-126-5p | Rheumatoid arthritis | MNDR-E-MI-08158 |
| MNDR | hsa-miR-126-5p | T-cell leukemia | MNDR-E-MI-08159 |
| MNDR | hsa-miR-126-5p | Retinoblastoma | MNDR-E-MI-08160 |
| MNDR | hsa-miR-126-5p | Chronic fatigue syndrome | MNDR-E-MI-08161 |
| MNDR | hsa-miR-126-5p | Hodgkin lymphoma | MNDR-E-MI-08162 |
| MNDR | hsa-miR-126-5p | Burkitt lymphoma | MNDR-E-MI-08163 |
| MNDR | hsa-miR-126-5p | Neuromyelitis optica | MNDR-E-MI-08164 |
| MNDR | hsa-miR-126-5p | Skin cutaneous melanoma | MNDR-E-MI-08165 |
| MNDR | hsa-miR-126-5p | Skin melanoma | MNDR-E-MI-08166 |
| MNDR | hsa-miR-126-5p | Acute myelogenous leukemia | MNDR-E-MI-08167 |
| MNDR | hsa-miR-126-5p | Colorectal cancer | MNDR-E-MI-08168 |
| MNDR | hsa-miR-126-5p | Nasopharynx carcinoma | MNDR-E-MI-08169 |
| MNDR | hsa-miR-126-5p | Acute lymphocytic leukemia | MNDR-E-MI-08170 |
| MNDR | hsa-miR-126-5p | Cardiomegaly | MNDR-E-MI-08171 |
| MNDR | hsa-miR-126-5p | Nasopharyngeal cancer | MNDR-E-MI-08172 |
| MNDR | hsa-miR-126-5p | Prostatic neoplasms | MNDR-E-MI-08173 |
| MNDR | hsa-miR-126-5p | Stable angina pectoris | MNDR-E-MI-08174 |
| MNDR | hsa-miR-126-5p | Breast cancer her3+ negative | MNDR-E-MI-08175 |
| MNDR | hsa-miR-126-5p | Low grade dysplastic nodule | MNDR-E-MI-08176 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADAM9 | Homo sapiens | RR00041156 |
TOP